Comparative effectiveness of spironolactone versus oral tetracycline-class antibiotics for the treatment of moderate to severe acne in women

螺内酯与口服四环素类抗生素治疗女性中度至重度痤疮的疗效比较

基本信息

  • 批准号:
    9815052
  • 负责人:
  • 金额:
    $ 24.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Acne is one of the most common diseases worldwide, affecting 85% of adolescents and often persisting into adulthood. Acne is responsible for a greater global burden of disease than psoriasis, cellulitis, and melanoma. While mild acne can usually be managed with topical medications, moderate to severe acne often requires treatment with systemic agents such as oral antibiotics, hormonal therapies, and isotretinoin. Remarkably, while these agents are a standard part of care, there are very few randomized clinical trials showing efficacy and none that show comparative effectiveness between these commonly used agents; the Institute of Medicine has identified this area as one of the top priorities for comparative effectiveness research. Previous work by our group has shown oral antibiotics are the most common systemic agent used in the treatment of acne and patients frequently use them for more than one year. In fact, dermatologists prescribe more antibiotics per capita than any other specialty. However, prolonged antibiotic use may be associated with a variety of adverse outcomes including bacterial antibiotic resistance, pharyngitis, collagen vascular illnesses, inflammatory bowel disease, and breast and colon cancer. As a result, there is growing international interest and attention specifically from the Centers for Disease Control regarding improving antibiotic stewardship in the outpatient setting and multiple clinical guidelines for acne have recommended reducing the use of antibiotics through the use of non-antimicrobial therapies and by limiting the duration of therapy. For women with moderate to severe acne, spironolactone may represent an effective, well-tolerated alternative to oral antibiotics. Developed as a potassium-sparing diuretic, for many years it has also been used off-label for acne due to its impact on hormonal pathogenesis of this disease. However, despite expert opinion supporting the use of spironolactone in the treatment of acne, its use remains relatively uncommon and clinical evidence demonstrating the effectiveness of spironolactone is limited to small, often retrospective studies. Trials comparing the effectiveness of spironolactone to that of other agents such as oral antibiotics are lacking. Our ultimate goal is to complete the necessary planning and preparation to conduct a novel, prospective, randomized clinical trial evaluating the comparative effectiveness of spironolactone and oral tetracycline-class antibiotics in the treatment of acne in adult women. No such study has previously been conducted. The results of this study would have substantial implications for the treatment of acne and antibiotic stewardship. In addition, this study may allow us to monitor for the timing of the development of antibiotic resistance in a healthy population of patients treated with extended courses of antibiotics and to evaluate the impact of prolonged exposure to oral antibiotics on the microbiome. Our proposed study could significantly influence healthcare practice with respect to the treatment of moderate to severe acne in women and inform policy regarding more appropriate use of antibiotics throughout medicine.
项目总结/摘要 痤疮是世界范围内最常见的疾病之一,影响85%的青少年,并且经常持续存在 长大成人痤疮是负责一个更大的全球疾病负担比牛皮癣,蜂窝织炎, 黑素瘤虽然轻度痤疮通常可以用局部药物治疗,但中度至重度痤疮通常 需要用全身性药物如口服抗生素、激素疗法和异维甲酸治疗。 值得注意的是,虽然这些药物是护理的标准部分,但很少有随机临床试验 这些常用药物之间显示出有效性,而没有显示出比较有效性; 医学研究所已将这一领域确定为比较有效性研究的首要任务之一。 我们小组以前的工作表明,口服抗生素是最常见的全身性药物, 治疗痤疮和患者经常使用它们超过一年。事实上,皮肤科医生会开 人均抗生素比其他任何专科都多。然而,长期使用抗生素可能与 各种不良后果,包括细菌抗生素耐药性,咽炎,胶原血管疾病, 炎症性肠病以及乳腺癌和结肠癌。因此,国际社会对 疾病控制中心特别关注改善抗生素管理, 门诊设置和痤疮的多个临床指南建议减少使用 通过使用非抗菌治疗和限制治疗持续时间来减少抗生素。 对于中度至重度痤疮的女性,螺内酯可能是一种有效的,耐受性良好的药物, 替代口服抗生素。作为一种保钾利尿剂开发,多年来它也被用于 由于其对这种疾病的激素发病机制的影响,尽管专家认为 支持使用螺内酯治疗痤疮,其使用仍然相对罕见和临床 证明螺内酯有效性的证据仅限于小型的、通常是回顾性的研究。 缺乏将螺内酯与其他药物(如口服抗生素)的有效性进行比较的试验。 我们的最终目标是完成必要的规划和准备,进行一个新颖的,前瞻性的, 评价螺内酯和口服四环素类药物疗效的随机临床试验 痤疮的治疗方法有哪些?以前没有进行过这样的研究。结果 这项研究的结果将对痤疮的治疗和抗生素管理产生重大影响。在 此外,这项研究可能使我们能够监测抗生素耐药性发展的时间, 接受延长抗生素疗程治疗的健康患者人群,并评估 长期暴露于口服抗生素对微生物组的影响。我们提出的研究可能会显著影响 关于治疗女性中度至重度痤疮的医疗实践和知情政策 关于在整个医疗过程中更恰当地使用抗生素的建议。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Margolis其他文献

David Margolis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Margolis', 18)}}的其他基金

A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
  • 批准号:
    10296086
  • 财政年份:
    2021
  • 资助金额:
    $ 24.95万
  • 项目类别:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
  • 批准号:
    10470869
  • 财政年份:
    2021
  • 资助金额:
    $ 24.95万
  • 项目类别:
NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers
NOS1AP 和 Capon 与糖尿病足溃疡患者的愈合受损相关
  • 批准号:
    9925084
  • 财政年份:
    2018
  • 资助金额:
    $ 24.95万
  • 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
  • 批准号:
    9228322
  • 财政年份:
    2016
  • 资助金额:
    $ 24.95万
  • 项目类别:
Data Sciences and Informatics
数据科学和信息学
  • 批准号:
    10477235
  • 财政年份:
    2016
  • 资助金额:
    $ 24.95万
  • 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
  • 批准号:
    9868281
  • 财政年份:
    2016
  • 资助金额:
    $ 24.95万
  • 项目类别:
Data Sciences and Informatics
数据科学和信息学
  • 批准号:
    10663986
  • 财政年份:
    2016
  • 资助金额:
    $ 24.95万
  • 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
  • 批准号:
    8538377
  • 财政年份:
    2012
  • 资助金额:
    $ 24.95万
  • 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
  • 批准号:
    8370929
  • 财政年份:
    2012
  • 资助金额:
    $ 24.95万
  • 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
  • 批准号:
    8731122
  • 财政年份:
    2012
  • 资助金额:
    $ 24.95万
  • 项目类别:

相似海外基金

Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 24.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The impact of changes in social determinants of health on adolescent and young adult mental health during the COVID-19 pandemic: A longitudinal study of the Asenze cohort in South Africa
COVID-19 大流行期间健康社会决定因素的变化对青少年和年轻人心理健康的影响:南非 Asenze 队列的纵向研究
  • 批准号:
    10755168
  • 财政年份:
    2023
  • 资助金额:
    $ 24.95万
  • 项目类别:
A Priority Setting Partnership to Establish a Patient, Caregiver, and Clinician-identified Research Agenda for Adolescent and Young Adult Cancer in Canada
建立优先合作伙伴关系,以建立患者、护理人员和临床医生确定的加拿大青少年和年轻人癌症研究议程
  • 批准号:
    480840
  • 财政年份:
    2023
  • 资助金额:
    $ 24.95万
  • 项目类别:
    Miscellaneous Programs
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
  • 批准号:
    10678157
  • 财政年份:
    2023
  • 资助金额:
    $ 24.95万
  • 项目类别:
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
不同种族青少年和年轻成年癌症幸存者的生育经历:一项基于人群的研究
  • 批准号:
    10744412
  • 财政年份:
    2023
  • 资助金额:
    $ 24.95万
  • 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
  • 批准号:
    23K07305
  • 财政年份:
    2023
  • 资助金额:
    $ 24.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
  • 批准号:
    23H02874
  • 财政年份:
    2023
  • 资助金额:
    $ 24.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Effects of adolescent social isolation on adult decision making and corticostriatal circuitry
青少年社会隔离对成人决策和皮质纹状体回路的影响
  • 批准号:
    10756652
  • 财政年份:
    2023
  • 资助金额:
    $ 24.95万
  • 项目类别:
Adolescent trauma produces enduring disruptions in sleep architecture that lead to increased risk for adult mental illness
青少年创伤会对睡眠结构产生持久的破坏,从而导致成人精神疾病的风险增加
  • 批准号:
    10730872
  • 财政年份:
    2023
  • 资助金额:
    $ 24.95万
  • 项目类别:
Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors
使用量身定制的移动健康策略促进青少年和年轻癌症幸存者的体重管理
  • 批准号:
    10650648
  • 财政年份:
    2023
  • 资助金额:
    $ 24.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了